Wisconsin native, Dr. Mark Holterman, has had a 40-year career and it doesn’t look like he will stop anytime soon. Not only is he recognized world wide for his medical practice, but Dr. Mark Holterman is also a superb businessman and capitalist. He has founded companies that focuses on oncology, stem cell therapy and medical devices. He has used his background and expertise to develop advancements in biotechnology.
Dr. Mark’s company, Mariam Global Health, is dedicated to global medicine and medical advances around the world. The globally business management and investment firm assists healthcare companies in the research and exploring new technology in the field of biotechnology around the world. This is done by motivating companies and individuals to invest in healthcare oriented business.
Dr. Mark Holterman is flexible with his time and tries to prioritize as much as possible. Things that need the most attention are the things that he addresses first. He makes it a point not to get overwhelmed with his work. He begins and ends his day with prayer. He emphasizes asking experts for the advices and learn from their expertise. There is no point to become greedy with ideas (https://interview.net/dr-mark-holterman/).
According to Dr. Holterman, it is important to have a team that can be trusted with new ideas. He suggests that the team be used to look for weak spots in suggested ideas and what can be done to strengthen then. Don’t be afraid to ask for advice. That is the key for ideas to be successful.
In addition to his work with Mariam Global Health, Dr. Mark Holterman is currently professor of medicine at University of Illinois College of Medicine. He is also co-founder of the Alliances for the Advancement of Cellular Therapies, as well as a member of American Association of Clinical Anatomists.
You might say that medical interests runs in the family. Dr. Holterman is married with two sons. Both his wife and sons are also in the medical profession. His wife, Aixuan, is a surgeon who focuses her efforts on scientific research. Their two sons are currently professors in the biotechnology field.